UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index

Histopathology, 2006-05, Vol.48 (6), p.674-682

2006

Volltextzugriff (PDF)

The yin and yang of apolipoprotein CIII

Diabetes & metabolism, 2018-06, Vol.44 (3), p.303-304

2018

Volltextzugriff (PDF)

Role of apoptosis in pancreatic beta-cell death in diabetes

Diabetes (New York, N.Y.), 2001-02, Vol.50 (suppl 1), p.S44-S47

2001

Volltextzugriff (PDF)

Drug-related deaths in a university central hospital

European journal of clinical pharmacology, 2002-10, Vol.58 (7), p.479-482

2002

Volltextzugriff (PDF)

Islet insulin resistance promotes local apolipoprotein CIII production and beta cell failure

DIABETOLOGIA, 2014, Vol.57 (S1), p.S162

2014

Volltextzugriff (PDF)

Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle

International journal of molecular sciences, 2021-01, Vol.22 (2), p.932

2021

Volltextzugriff (PDF)

Protein kinase C modulates the insulin secretory process by maintaining a proper function of the beta-cell voltage-activated Ca2+ channels

The Journal of biological chemistry, 1994-01, Vol.269 (4), p.2743-2749

1994

Volltextzugriff (PDF)

Identification of Synaptic Proteins and Their Isoform mRNAs in Compartments of Pancreatic Endocrine Cells

Proceedings of the National Academy of Sciences - PNAS, 1994-12, Vol.91 (26), p.12487-12491

1994

Volltextzugriff (PDF)

Apolipoprotein CIII is a new player in diabetes

Current opinion in lipidology, 2017-02, Vol.28 (1), p.27-31

2017

Volltextzugriff (PDF)

Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII

BioFactors (Oxford), 2023-01, Vol.49 (1), p.153-172

2023

Volltextzugriff (PDF)

Apolipoprotein CIII Reduction Protects White Adipose Tissues against Obesity-Induced Inflammation and Insulin Resistance in Mice

International journal of molecular sciences, 2022-01, Vol.23 (1), p.62

2022

Volltextzugriff (PDF)

ATF5 is a regulator of ER stress and β-cell apoptosis in different mouse models of genetic- and diet-induced obesity and diabetes mellitus

Cellular signalling, 2023-02, Vol.102, p.110535-110535, Article 110535

2023

Volltextzugriff (PDF)

Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes

Proceedings of the National Academy of Sciences - PNAS, 2015-05, Vol.112 (20), p.E2611-E2619

2015

Volltextzugriff (PDF)

Breathless after separation... from tumour

The European respiratory journal, 2008-11, Vol.32 (5), p.1420-1421

2008

Volltextzugriff (PDF)

The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients

Diabetes care, 1996-11, Vol.19 (11), p.1200-1206

1996

Volltextzugriff (PDF)

Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials

Viral immunology, 2020-11, Vol.33 (9), p.594-599

2020

Volltextzugriff (PDF)

BioBreeding rat diabetes model is infected with Ljungan virus

Diabetologia, 2007-07, Vol.50 (7), p.1559-1560

2007

Volltextzugriff (PDF)

C-Peptide Replacement Therapy and Sensory Nerve Function in Type 1 Diabetic Neuropathy

Diabetes care, 2007, Vol.30 (1), p.71-76

2007

Volltextzugriff (PDF)

Islet Transplantation to the Anterior Chamber of the Eye—A Future Treatment Option for Insulin-Deficient Type-2 Diabetics? A Case Report from a Nonhuman Type-2 Diabetic Primate

Cell transplantation, 2020-01, Vol.29, p.963689720913256-963689720913256

2020

Volltextzugriff (PDF)

Cathelicidins positively regulate pancreatic β‐cell functions

The FASEB journal, 2016-02, Vol.30 (2), p.884-894

2016

Volltextzugriff (PDF)

Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas

Diabetes care, 1996-08, Vol.19 (8), p.857-863

1996

Volltextzugriff (PDF)

Ca2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells

Journal of lipid research, 1997-10, Vol.38 (10), p.2049-2061

1997

Volltextzugriff (PDF)

Lowering apolipoprotein CIII delays onset of type 1 diabetes

Proceedings of the National Academy of Sciences - PNAS, 2011-06, Vol.108 (26), p.10685-10689

2011

Volltextzugriff (PDF)

Defects in β-cell Ca2+ dynamics in age-induced diabetes

Diabetes (New York, N.Y.), 2014-12, Vol.63 (12), p.4100-4114

2014

Volltextzugriff (PDF)

Predictors of cognitive impairment in type 1 diabetes

Psychoneuroendocrinology, 2007-09, Vol.32 (8), p.1041-1051

2007

Volltextzugriff (PDF)

1 – 25 von 167

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(141)
Mit Volltextzugriff
(138)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ki67 immunohistochemistry: a valuable marker in prognostication but with a risk of misclassification: proliferation subgroups formed based on Ki67 immunoreactivity and standardized mitotic index

The yin and yang of apolipoprotein CIII

Role of apoptosis in pancreatic beta-cell death in diabetes

Drug-related deaths in a university central hospital

Islet insulin resistance promotes local apolipoprotein CIII production and beta cell failure

Apolipoprotein CIII Is an Important Piece in the Type-1 Diabetes Jigsaw Puzzle

Protein kinase C modulates the insulin secretory process by maintaining a proper function of the beta-cell voltage-activated Ca2+ channels

Identification of Synaptic Proteins and Their Isoform mRNAs in Compartments of Pancreatic Endocrine Cells

Apolipoprotein CIII is a new player in diabetes

Treatment of the metabolic syndrome by siRNA targeting apolipoprotein CIII

Apolipoprotein CIII Reduction Protects White Adipose Tissues against Obesity-Induced Inflammation and Insulin Resistance in Mice

ATF5 is a regulator of ER stress and β-cell apoptosis in different mouse models of genetic- and diet-induced obesity and diabetes mellitus

Apolipoprotein CIII links islet insulin resistance to β-cell failure in diabetes

Breathless after separation... from tumour

The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients

Effectiveness of Antivirals in a Type 1 Diabetes Model and the Move Toward Human Trials

BioBreeding rat diabetes model is infected with Ljungan virus

C-Peptide Replacement Therapy and Sensory Nerve Function in Type 1 Diabetic Neuropathy

Islet Transplantation to the Anterior Chamber of the Eye—A Future Treatment Option for Insulin-Deficient Type-2 Diabetics? A Case Report from a Nonhuman Type-2 Diabetic Primate

Cathelicidins positively regulate pancreatic β‐cell functions

Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas

Ca2+ channel blockers verapamil and nifedipine inhibit apoptosis induced by 25-hydroxycholesterol in human aortic smooth muscle cells

Lowering apolipoprotein CIII delays onset of type 1 diabetes

Defects in β-cell Ca2+ dynamics in age-induced diabetes

Predictors of cognitive impairment in type 1 diabetes

Suchergebnisse filtern